Food Allergy News

Last week, a preview of the planned Uber Eats Super Bowl commercial, “Don’t Forget,” sparked condemnation from the food allergy community regarding the depiction of an adult having an allergic reaction to the ingestion of peanut butter.

More than half of the children with an IgE-mediated cow’s milk allergy at age 6 years acquired tolerance to cow’s milk by age 12 years without oral immunotherapy, according to a study published in Pediatric Allergy and Immunology.

ARS Pharma continues to study the effectiveness and safety of its neffy epinephrine nasal spray as patients with allergies wait for an alternative to autoinjectors for anaphylaxis treatment.

Black children had higher odds for severe food allergy reactions and E usage as well as lower total lifetime epinephrine use than white children, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA has granted an orphan drug designation to ’1104 from Revolo Biotherapeutics, a first-in-class immune-resetting peptide designed to treat eosinophilic esophagitis, according to a press release.

Treatment options for children with eosinophilic esophagitis have expanded with the FDA’s approval of dupilumab for those aged 1 to 11 years who weigh at least 15 kg, according to a press release.

Healio compiled the most-read news in allergy, asthma and immunology posted in January.

Adults experienced limited success with oral immunotherapy for food allergies, with about half of a cohort halting treatment within 2 years, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA has approved the use of dupilumab for treating eosinophilic esophagitis in children aged 1 to 11 years who weigh at least 15 kg, according to a press release.

Researchers found low rates of new peanut allergy and generally low rates of peanut discontinuation after introduction in a cohort of high-risk infants, according to study results published in The Journal of Allergy and Clinical Immunology.